Medicinal Chemistry (Biopharmaceutical Products)
Medicinal Chemistry (Biopharmaceutical Products) Companies (21)
Medicinal Chemistry (Biopharmaceutical Products) News
-
News PSCI launches progressive position on the use of Horseshoe Crabs
A quarterly series of articles about responsible supply chain management from the PSCI.
-
News Sai Life Sciences to boost biology capabilities at its integrated R&D campus
The CRDMO will expand in vitro and in vivo biology services, DMPK and toxicology capabilities. -
News BioAscent scientists help identify potential new treatments for cancer
Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. -
News GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’
China-US trade challenges has led to de-risking by pharma companies.
Medicinal Chemistry (Biopharmaceutical Products) Products (89)
-
Product Research & Development
Discovery - Biology, Lead Optimization, Libraries, Synthetic & Medicinal ChemistryDevelopment - Chemical Process R&D, Fermentation, Formulation Development, High Potency, Kilo Lab & Small Scale Manufacturing, Lipid Nanoparticle, Method Development/Material Science, Rare/Orphan, Separation Scien...
-
Product Drug Substance
Recipharm has more than 25 years’ experience in drug substance development and manufacturing. We are ideally placed to deliver a wide range of drug substance services from our dedicated development facilities around the world.
-
Product 07. FOGYMA PLUS (Iron (III) hydroxide polymaltose)
Composition: Each 10ml ampoule contains:Iron (as Iron (III) hydroxide polymaltose) 50mg, Acid Folic 500mg, Vitamin B12 0.5 mcg.
Dosage Form: Oral solution
Indication: Prevention and supported treatment of iron deficiency inanemia.
Use for Pregnant, Breastfeed...
-
Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia
-
Product Olostar 20/10mg and 40/20mg - Tab.
Olmesartan medoxomil, Rosuvastatin
Indication: Concomitant Hypertension and Dyslipidemia
<World's 1st fixed dose combination of olmesartan and rosuvastatin>
1. Developed with Daewoong's patented formulation technology
2. Indicated for the treatment of both hypertensio...
-
Product 2-(tert-butoxycarbonyl)-2-azabicyclo[2.1.1]hexane-4-carboxylic acid
2-azabicyclo[2.1.1]hexane-2,4-dicarboxylic acid, 2-(1,1-dimethylethyl) ester
-
Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemi...
-
Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion
Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia
-
Product Synthetic Chemistry
Recipharm offer a range of synthetic chemistry services through our global development facilities including advanced lead optimisation medicinal chemistry, process development and tech transfer to large scale GMP-manufacturing and other specialties.
-
Product URSA
25, 50, 100, 200, 250, 300mg - Tab., Soft Cap., Hard Cap.
UDCA (Ursodeoxycholic Acid)
Indication:
Cholestasis(include PBC, PSC), Viral hepatitis C, Gallstone
URSA improves liver function in chronic hepatitis patients, improves symptom and histopathology in Cholestatis...
-
Product 3-methylbicyclo[1.1.1]pentan-1-amine hydrochloride
3-Methylbicyclo[1.1.1]pentan-1-aminehydrochloride
-
Product 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylic acid
3-[(TERT-BUTOXYCARBONYL)AMINO]BICYCLO[1.1.1]PENTANE-1-CARBOXYLIC ACID
-
Product trans-3-amino-1-methylcyclobutan-1-ol hydrochloride
trans-3-Hydroxy-3-MethylcyclobutylaMine hydrochloride
-
Product tert-butyl (S)-3-(2-hydroxyethyl)piperazine-1-carboxylate
(S)-tert-butyl 3-(2-Hydroxyethyl)piperazine-1-carboxylate
-
Product tert-butyl (R)-3-methyl-4-oxopiperidine-1-carboxylate
1-Piperidinecarboxylic acid, 3-methyl-4-oxo-, 1,1-dimethylethyl ester, (3R)-
Upcoming Events
-
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026 -
PMEC India 2026
IEML, Greater Noida, Delhi
24 Nov 2026 - 26 Nov 2026 -
Pharmapack Europe 2027
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
27 Jan 2027 - 28 Jan 2027



